Edex and Keratorhexis - a phase IV clinical study of FDA data
We study 579 people who take Edex or have Keratorhexis. No report of Keratorhexis is found in people who take Edex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Edex?
Edex has active ingredients of alprostadil. eHealthMe is studying from 460 Edex users for its effectiveness, alternative drugs and more.
What is Keratorhexis?
Keratorhexis (rupture of the cornea) is found to be associated with 142 drugs and 127 conditions by eHealthMe.
Do you take Edex and have Keratorhexis?Check whether Keratorhexis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Keratorhexis and when was it recovered:
Expand to all the drugs that have ingredients of alprostadil:
Alternative drugs to, pros and cons of Edex:
- Edex (460 reports)
Keratorhexis treatments and more:
- Keratorhexis (119 reports)
COVID vaccines that are related to Keratorhexis:
- Keratorhexis in Moderna COVID Vaccine
- Keratorhexis in Pfizer BioNTech Covid Vaccine
- Keratorhexis in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Keratorhexis:
All the conditions that are associated with Keratorhexis:
How the study uses the data?
The study uses data from the FDA. It is based on alprostadil (the active ingredients of Edex) and Edex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Albuterol and Gouty Tophus - 6 seconds ago
- Isosorbide Mononitrate and Brovana drug interaction - 8 seconds ago
- Tolterodine and Cabergoline drug interaction - 15 seconds ago
- Cymbalta and Mitoxantrone drug interaction - 18 seconds ago
- Conzip and Celebrex drug interaction - 18 seconds ago
- Orencia and Irritability - 21 seconds ago
- Cefuroxime Sodium and Rabeprazole Sodium drug interaction - 29 seconds ago
- Colchicine and Iga Nephropathy - 45 seconds ago
- Acth and Anger - 56 seconds ago
- Cytomel and Xopenex drug interaction - a minute ago